Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo

Other

Nagase Viita Co., Ltd.

Osamu Sano

Masashi Kurimoto

Yoshiaki Yanai

Keizo Kohno

Iwao Okamoto

Akiko Miyake

Norie Arai

Hirofumi Kunitake

The present invention has objects to provide a novel crystalline 2-O-α-D-glucosyl-L-ascorbic acid and method for producing the same. The present invention solves the above objects by providing crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid and method for producing the same.

Crystalline potassium salt of 2-O-α-D-glucosyl-L-ascorbic acid and method for producing the same

It is intended to provide an anti-allergic agent, which efficaciously relieves symptoms accompanying an allergic disease without causing any serious side effect. This object is achieved by providing an anti-allergic agent which contains, as an effective ingredient, proteins collected from royal jelly or purified royal jelly, or royal jelly or purified royal jelly containing the proteins.

Antiallergic agent

The objects of the present invention are to reveal a specific combination of human interferon-&#x3b1; subtypes that remarkably enhances the expression of protein synthesis inhibitory genes, and to provide an expression enhancer comprising as effective ingredients interferon-&#x3b1; subtypes in such a combination and uses thereof. The above objects are solved by providing an expression enhancer for protein synthesis inhibitory genes which comprises as effective ingredients interferon-&#x3b1;2 and interferon-&#x3b1;8 subtypes of human interferon-&#x3b1;, and uses thereof including pharmaceuticals.

Pharmaceutical composition of human interferon-&#x3b1;2 and interferon &#x3b1;8 subtypes

The objects of the present invention are to reveal a specific combination of human interferon-&agr; subtypes that remarkably enhances the expression of protein synthesis inhibitory genes, and to provide an expression enhancer comprising as effective ingredients interferon-&agr; subtypes in such a combination and uses thereof. The above objects are solved by providing an expression enhancer for protein synthesis inhibitory genes which comprises as effective ingredients interferon-&agr;2 and interferon-&agr;8 subtypes of human interferon-&agr;, and uses thereof including pharmaceuticals.

Growing community of inventors

Okayama, Japan

Osamu Sano